---
tags:
  - Pharmacology
edited: 2024-01-27
---

| Type                                | 1st line                                                                                            | 2nd line                |
| ----------------------------------- | --------------------------------------------------------------------------------------------------- | ----------------------- |
| Focal                               | [[Lamotrigine]], [[Levetiracetam]], [[Phenytoin]], [[Carbamazepine]], **Phenobarbital in children** | [[Sodium Valproate]]    |
| Grand-mal                           | Lamotrigine, Valproate, [[Phenobarbital]] in children                                               | Carbamazepine           |
| Absence                             | [[Ethosuximide]], Valproate                                                                         | Lamotrigine, Clonazepam |
| Atypical absence, Myoclonic, Atonic | Valproate, **Lamotrigine**, [[Topiramate]]                                                          | Clonazepam              |
### Regimen
- Monotherapy is maintained if possible
	- Alternate drug with tapering if ineffective
	- Approx. ⅔ of epilepsy patients become seizure-free with monotherapy
- Combination only if monotherapy fails
	- Drugs with different MOA
	- Only 15–30% of patients on combination therapy become seizure‑free.
- Failure of combination: [[Drug-resistant epilepsy]] 
	- Non-pharmacological
### When to termination
- Consider if patient meets all of the following
	- < 2 seizures/year
	- An inconspicuous provocation EEG
	- Normal psychological findings
	- No hereditary predisposition
- Generally possible after 2–5 seizure‑free years with normal EEG results

### Drug classification
![[Pasted image 20240502132614.png]]

---
### *Related
- [[DRESS]] 